Novartis chief sees remote-work hybrid persisting after pandemic
Novartis, the Swiss pharma giant, is rethinking its use of office space as a hybrid of at-home and in-office work extends beyond the pandemic.
By Naomi Kresge, Bloomberg
(Bloomberg) --Novartis, the Swiss pharma giant, is rethinking its use of office space as a hybrid of at-home and in-office work extends beyond the pandemic.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
